This report provides a comprehensive analysis of AstraZeneca's strategic management practices, particularly in the context of the COVID-19 pandemic. It begins with an introduction to strategic management and sustainability, highlighting the pressures faced by pharmaceutical companies like AstraZeneca. The main body of the report delves into AstraZeneca's key business strategies, using Porter's generic strategies and Ansoff's matrix to illustrate its approaches to cost leadership, differentiation, cost focus, market penetration, product development, market development, and diversification. The report also examines AstraZeneca's resource capabilities, employing the VRIO framework to assess the value, rarity, imitability, and organization of its resources. Finally, it addresses AstraZeneca's environmental sustainability approaches, emphasizing the importance of sustainable practices in the pharmaceutical industry. The report concludes with a summary of the key findings and a list of references.
![[object Object]](/_next/static/media/star-bottom.7253800d.svg)
